They emphasize the therapeutic potential of CBD in contrast to THC, a psychoactive ingredient that causes dependence
They are good times for marijuana lovers, both in its more playful aspect and for those who use it as a remedy to treat diseases or other ailments. Recently, World Health Organization (WHO) has ensured that cannabidiol (CBD), the second most important ingredient of cannabis, is a “safe” and “non-addictive” substance that does not seem to have “any potential for abuse or dependence” on the marijuana consumer.
This statement comes from WHO Expert Committee on Drug Addiction, which concludes that CBD does not produce any significant psychoactive or cardiovascular effects. In addition, they support researches that conclude this substance is a medicinal product. This has proven its usefulness in figthing epilepsy, Parkinson’s or chronic pain, among other diseases.
On the other hand, they ensure that tetrahydrocannabinol (THC) must be considered as a psychoactive substance, since it is the cause of dependence on marijuana and the one that generates addiction to cannabis.
WHO does not recommend its consumption
Despite these statements, WHO’s intend is not to recommend CBD using. This exhaustive examination is simply due to the need for a response from WHO countries. For the same reason, during this year another more in-depth study of cannabis and cannabidiol will be carried out.
The fact that WHO has put its sights on cannabis is due to the undeniable current trend that marijuana using is increasing. Today, more and more countries and regions have legalized or are in the process of regulating their consumption, both medicinal and recreational. In South America, Uruguay leads the pro-legalization countries list, and in the United States, there are several States that have joined this trend.